The use of CT colonography (CTC) for colorectal cancer (CRC) screening prevents more cancers and is more cost-effective than multitarget stool DNA testing, a simulation study suggested. In a ...

Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger adults, a new study says. More 45- to 49-year-olds went ahead with cancer ...

Mayo Clinic researchers conducted a study comparing the efficacy of multitarget stool DNA tests to fecal immunochemical testing for colorectal cancer screening in Alaska Native people. Here are six ...

Last week, shares of Cologuard dropped following a U.S. Preventative Services Task Force rating announcement. But, a new study of patient preferences could affect the USPSTF’s final recommendations, ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced adenomas (AA). The CRC-PREVENT study evaluated more ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...